Porter et al., who measured maternal plasma NRP-1 using the ELISA method in IUGR pregnancies compared to healthy pregnancies, found a significant decrease in maternal plasma soluble NRP-1 (sNRP1) concentrations in growth-restricted pregnancies with fetoplacental circulatory disorders. The gene discussed is NRP1; the disease is fetal growth restriction.